AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

Social anxiety disorder is sustained, in part, by distorted thoughts about oneself and the belief that one needs to be ...

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

The more that we cannot tolerate anxiety, the more anxious we get.

Seaport’s pipeline also includes SPT-320 (formerly LYT-320), a novel prodrug of agomelatine being advanced into Phase I ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...